Our services

Reprogramming somatic cells from both healthy donors and patients into high-quality, validated iPSC clones using footprint-free, integration-free methods — ideal for research, disease modeling, and drug discovery workflows.

We generate 3D spheroid and organoid models from both healthy and patient-derived iPSCs. These models serve as powerful tools for academic and industrial research in disease modeling and therapy development, while helping to reduce reliance on animal testing.

Human iPSC-derived 3D models provide physiologically relevant platforms for assessing compound safety and efficacy. Our assays support target validation, mechanism-of-action studies, and translational preclinical development.

GLP-compliant testing services using human 2D and 3D cell-based models — designed for pharmaceutical, cosmetic, and medical device development. Our assays deliver reliable, high-quality data in line with regulatory standards.